$1.21
3.97% yesterday
Nasdaq, Aug 12, 10:14 pm CET

Pacific Biosciences of California, Inc. Stock price

$1.21
-0.25 17.12% 1M
-0.15 11.03% 6M
-0.62 33.88% YTD
-0.22 15.38% 1Y
-7.58 86.23% 3Y
-4.31 78.08% 5Y
-3.31 73.23% 10Y
-15.23 92.64% 20Y
Nasdaq, Closing price Tue, Aug 12 2025
-0.05 3.97%

Key metrics

Basic
Market capitalization
$378.5m
Enterprise Value
$681.6m
Net debt
$303.1m
Cash
$343.1m
Shares outstanding
300.0m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
2.5 | 2.4
EV/Sales
4.5 | 4.3
EV/FCF
negative
P/B
4.1
Financial Health
Equity Ratio
40.2%
Return on Equity
-61.2%
ROCE
-74.4%
ROIC
-122.4%
Debt/Equity
7.1
Financials (TTM | estimate)
Revenue
$152.4m | $159.2m
EBITDA
$-216.4m | $-108.5m
EBIT
$-590.9m | $-391.7m
Net Income
$-657.8m | $-446.4m
Free Cash Flow
$-183.1m
Growth (TTM | estimate)
Revenue
-24.0% | 3.4%
EBITDA
31.3% | 56.6%
EBIT
-80.9% | -46.2%
Net Income
-121.5% | -44.1%
Free Cash Flow
26.5%
Margin (TTM | estimate)
Gross
19.5%
EBITDA
-142.0% | -68.2%
EBIT
-387.9%
Net
-431.7% | -280.4%
Free Cash Flow
-120.2%
More
EPS
$-2.2
FCF per Share
$-0.6
Short interest
16.8%
Employees
575
Rev per Employee
$270.0k
Show more

Is Pacific Biosciences of California, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

Pacific Biosciences of California, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

20 Analysts have issued a Pacific Biosciences of California, Inc. forecast:

11x Buy
55%
9x Hold
45%

Analyst Opinions

20 Analysts have issued a Pacific Biosciences of California, Inc. forecast:

Buy
55%
Hold
45%

Financial data from Pacific Biosciences of California, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
152 152
24% 24%
100%
- Direct Costs 123 123
14% 14%
81%
30 30
49% 49%
19%
- Selling and Administrative Expenses 153 153
12% 12%
100%
- Research and Development Expense 113 113
38% 38%
74%
-216 -216
31% 31%
-142%
- Depreciation and Amortization 375 375
3,112% 3,112%
246%
EBIT (Operating Income) EBIT -591 -591
81% 81%
-388%
Net Profit -658 -658
122% 122%
-432%

In millions USD.

Don't miss a Thing! We will send you all news about Pacific Biosciences of California, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Pacific Biosciences of California, Inc. Stock News

Neutral
Seeking Alpha
4 days ago
Pacific Biosciences of California, Inc. (NASDAQ:PACB ) Q2 2025 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants Christian O. Henry - President, CEO & Director James R.
Positive
The Motley Fool
5 days ago
PACB Sales Up 11%
Neutral
GlobeNewsWire
7 days ago
MENLO PARK, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be participating in the following upcoming investor conferences:
More Pacific Biosciences of California, Inc. News

Company Profile

Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. Its products and services include PacBio sequel system, consumables, analytical software, and single molecule real-time (SMRT) compatible products. It operates through the following geographical segments: North America, Europe, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.

Head office United States
CEO Christian Henry
Employees 575
Founded 2000
Website www.pacb.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today